Skip to main content
Top
Published in: Nutrition & Metabolism 1/2011

Open Access 01-12-2011 | Research

Impact of chromium histidinate on high fat diet induced obesity in rats

Authors: Mehmet Tuzcu, Nurhan Sahin, Cemal Orhan, Can Ali Agca, Fatih Akdemir, Zeynep Tuzcu, James Komorowski, Kazim Sahin

Published in: Nutrition & Metabolism | Issue 1/2011

Login to get access

Abstract

Background

Chromium (Cr) is an essential trace element that has garnered interest for use as a weight loss aid, but its molecular mechanism in obesity is not clear. In this study, an attempt has been made to investigate the effects of chromium histidinate (CrHis) on glucose transporter-2 (GLUT-2), nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1), nuclear factor-kappa B (NF-κB p65) and the oxidative stress marker 4-hydroxynonenal adducts (HNE) expressions in liver of rats fed high fat diet (HFD).

Methods

Male Wistar rats (n = 40, 8 wk-old) were divided into four groups. Group I was fed a standard diet (12% of calories as fat); Group II was fed a standard diet and supplemented with 110 μg CrHis/kg BW/d; Group III was fed a HFD (40% of calories as fat); Group IV was fed HFD and supplemented with 110 μg CrHis/kg BW/d.

Results

Rats fed HFD possessed greater serum insulin (40 vs.33 pmol/L) and glucose (158 vs. 143 mg/dL) concentration and less liver Cr (44 vs.82 μg/g) concentration than rats fed the control diet. However, rats supplemented with CrHis had greater liver Cr and serum insulin and lower glucose concentration in rats fed HFD (P < 0.05). The hepatic nuclear factor-kappa B (NF-κB p65) and HNE were increased in high fat group compared to control group, but reduced by the CrHis administration (P < 0.05). The levels of hepatic Nrf2 and HO-1 were increased by supplementation of CrHis (P < 0.05).

Conclusion

These findings demonstrate that supplementation of CrHis is protective against obesity, at least in part, through Nrf2-mediated induction of HO-1 in rats fed high fat diet.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fried M, Hainer V, Basdevant A, Buchwald H, Dietel M, Finer N, Greve JW, Horber F, Mathus-Vliegen E, Scopinaro N: Interdisciplinary European guidelines on surgery for severe obesity. Rozhl Chir. 2008, 87: 468-476. Fried M, Hainer V, Basdevant A, Buchwald H, Dietel M, Finer N, Greve JW, Horber F, Mathus-Vliegen E, Scopinaro N: Interdisciplinary European guidelines on surgery for severe obesity. Rozhl Chir. 2008, 87: 468-476.
2.
go back to reference Yalniz M, Bahcecioglu IH, Kuzu N, Poyrazoglu OK, Bulmus O, Celebi S, Ustundag B, Ozercan IH, Sahin K: Preventive role of genistein in an experimental non-alcoholic steatohepatitis model. J Gastroenterol Hepatol. 2007, 22: 2009-2014. 10.1111/j.1440-1746.2006.04681.x.CrossRef Yalniz M, Bahcecioglu IH, Kuzu N, Poyrazoglu OK, Bulmus O, Celebi S, Ustundag B, Ozercan IH, Sahin K: Preventive role of genistein in an experimental non-alcoholic steatohepatitis model. J Gastroenterol Hepatol. 2007, 22: 2009-2014. 10.1111/j.1440-1746.2006.04681.x.CrossRef
3.
go back to reference Pagotto U, Vanuzzo D, Vicennati V, Pasquali RG: Pharmacological therapy of obesity. G Ital Cardiol (Rome). 2008, 9: 83-93. Pagotto U, Vanuzzo D, Vicennati V, Pasquali RG: Pharmacological therapy of obesity. G Ital Cardiol (Rome). 2008, 9: 83-93.
4.
go back to reference Lavie CJ, Artham SM, Milani RV, Ventura HO: The obesity paradox: impact of obesity on the prevalence prognosis of cardiovascular diseases. Postgrad Med. 2008, 120: 34-41. 10.3810/pgm.2008.07.1788.CrossRef Lavie CJ, Artham SM, Milani RV, Ventura HO: The obesity paradox: impact of obesity on the prevalence prognosis of cardiovascular diseases. Postgrad Med. 2008, 120: 34-41. 10.3810/pgm.2008.07.1788.CrossRef
5.
go back to reference Flanagan AM, Brown JL, Santiago CA, Aad PY, Spicer LJ, Spicer MT: High-fat diets promote insulin resistance through cytokine gene expression in growing female rats. J Nutr Biochem. 2007, 19: 505-513.CrossRef Flanagan AM, Brown JL, Santiago CA, Aad PY, Spicer LJ, Spicer MT: High-fat diets promote insulin resistance through cytokine gene expression in growing female rats. J Nutr Biochem. 2007, 19: 505-513.CrossRef
6.
go back to reference Ikehara O, Kawasaki N, Maezono K, Komatsu M, Konishi A: Acute and chronic treatment of L-isoleucine ameliorates glucose metabolism in glucose-intolerant and diabetic mice. Biol Pharm Bull. 2008, 31: 469-472. 10.1248/bpb.31.469.CrossRef Ikehara O, Kawasaki N, Maezono K, Komatsu M, Konishi A: Acute and chronic treatment of L-isoleucine ameliorates glucose metabolism in glucose-intolerant and diabetic mice. Biol Pharm Bull. 2008, 31: 469-472. 10.1248/bpb.31.469.CrossRef
7.
go back to reference Ribeiro MC, Barbosa NB, de Almeida TM, Parcianello LM, Perottoni J, de Avila DS, Rocha JB: High-fat diet and hydrochlorothiazide increase oxidative stress in brain of rats. Cell Biochem Funct. 2009, 27: 473-478. 10.1002/cbf.1599.CrossRef Ribeiro MC, Barbosa NB, de Almeida TM, Parcianello LM, Perottoni J, de Avila DS, Rocha JB: High-fat diet and hydrochlorothiazide increase oxidative stress in brain of rats. Cell Biochem Funct. 2009, 27: 473-478. 10.1002/cbf.1599.CrossRef
8.
go back to reference Oben JE, Enyegue DM, Fomekong GI, Soukontoua YB, Agbor GA: The effect of Cissus quadrangularis (GQR-300) and a Cissus formulation (CORE) on obesity and obesity-induced oxidative stress. Lipids Health Dis. 2007, 6: 4-12. 10.1186/1476-511X-6-4.CrossRef Oben JE, Enyegue DM, Fomekong GI, Soukontoua YB, Agbor GA: The effect of Cissus quadrangularis (GQR-300) and a Cissus formulation (CORE) on obesity and obesity-induced oxidative stress. Lipids Health Dis. 2007, 6: 4-12. 10.1186/1476-511X-6-4.CrossRef
9.
go back to reference Lieber CS, Leo MA, Mak KM, Xu Y, Cao Q, Ren C, Ponomarenko A, DeCarli LM: Model of nonalcoholic steatohepatitis. Am J Clin Nutr. 2004, 79: 502-509. Lieber CS, Leo MA, Mak KM, Xu Y, Cao Q, Ren C, Ponomarenko A, DeCarli LM: Model of nonalcoholic steatohepatitis. Am J Clin Nutr. 2004, 79: 502-509.
10.
go back to reference Kim SJ, Choi Y, Jun HS, Kim BM, Na HK, Surh YJ, Park T: High-fat diet stimulates IL-1 type I receptor-mediated inflammatory signaling in the skeletal muscle of mice. Mol Nutr Food Res. 2010, 54: 1014-1020. 10.1002/mnfr.200800512.CrossRef Kim SJ, Choi Y, Jun HS, Kim BM, Na HK, Surh YJ, Park T: High-fat diet stimulates IL-1 type I receptor-mediated inflammatory signaling in the skeletal muscle of mice. Mol Nutr Food Res. 2010, 54: 1014-1020. 10.1002/mnfr.200800512.CrossRef
11.
go back to reference Pittler MH, Stevinson C, Ernst E: Chromium picolinate for reducing body weight: Meta-analysis of randomized trials. Int J Obesity. 2003, 27: 522-529. 10.1038/sj.ijo.0802262.CrossRef Pittler MH, Stevinson C, Ernst E: Chromium picolinate for reducing body weight: Meta-analysis of randomized trials. Int J Obesity. 2003, 27: 522-529. 10.1038/sj.ijo.0802262.CrossRef
12.
go back to reference Mertz W: Chromium in human nutrition: a review. J Nutr. 1993, 123: 626-633. Mertz W: Chromium in human nutrition: a review. J Nutr. 1993, 123: 626-633.
13.
go back to reference Anderson RA: Chromium, glucose tolerance, and diabetes. Biol Trace Elem Res. 1992, 32: 19-24. 10.1007/BF02784583.CrossRef Anderson RA: Chromium, glucose tolerance, and diabetes. Biol Trace Elem Res. 1992, 32: 19-24. 10.1007/BF02784583.CrossRef
14.
go back to reference Anderson RA: Chromium in the prevention and control of diabetes. Diabetes Metab. 2000, 26: 22-27. Anderson RA: Chromium in the prevention and control of diabetes. Diabetes Metab. 2000, 26: 22-27.
15.
go back to reference Mozaffari MS, Abdelsayed R, Liu JY, Wimborne H, El-Remessy A, El-Marakby A: Effects of chromium picolinate on glycemic control and kidney of the obese Zucker rat. Nutr Metab (Lond). 2009, 10: 6-51. Mozaffari MS, Abdelsayed R, Liu JY, Wimborne H, El-Remessy A, El-Marakby A: Effects of chromium picolinate on glycemic control and kidney of the obese Zucker rat. Nutr Metab (Lond). 2009, 10: 6-51.
16.
go back to reference Preuss HG, Grojec PL, Lieberman S, Anderson RA: Effects of different chromium compounds on blood pressure and lipid peroxidation in spontaneously hypertensive rats. Clin Nephrol. 1997, 47: 325-330. Preuss HG, Grojec PL, Lieberman S, Anderson RA: Effects of different chromium compounds on blood pressure and lipid peroxidation in spontaneously hypertensive rats. Clin Nephrol. 1997, 47: 325-330.
17.
go back to reference Sahin K, Onderci M, Tuzcu M, Ustundag B, Cikim G, Ozercan IH, Sriramoju V, Juturu V, Komorowski JR: Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metab Clin Exp. 2007, 56: 1233-1240.CrossRef Sahin K, Onderci M, Tuzcu M, Ustundag B, Cikim G, Ozercan IH, Sriramoju V, Juturu V, Komorowski JR: Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metab Clin Exp. 2007, 56: 1233-1240.CrossRef
18.
go back to reference Anderson RA, Polansky MM, Bryden NA: Stability and absorption of chromium and absorption of chromium histidinate complexes by humans. Biol Trace Elem Res. 2004, 101: 211-218. 10.1385/BTER:101:3:211.CrossRef Anderson RA, Polansky MM, Bryden NA: Stability and absorption of chromium and absorption of chromium histidinate complexes by humans. Biol Trace Elem Res. 2004, 101: 211-218. 10.1385/BTER:101:3:211.CrossRef
19.
go back to reference Kim BG, Lindemann MD, Cromwell GL: Effects of dietary chromium (III) picolinate on growth performance, respiratory rate, plasma variables, and carcass traits of pigs fed high-fat diets. Biol Trace Elem Res. 2010, 133: 181-96. 10.1007/s12011-009-8417-7.CrossRef Kim BG, Lindemann MD, Cromwell GL: Effects of dietary chromium (III) picolinate on growth performance, respiratory rate, plasma variables, and carcass traits of pigs fed high-fat diets. Biol Trace Elem Res. 2010, 133: 181-96. 10.1007/s12011-009-8417-7.CrossRef
20.
go back to reference DeAngelis RA, Markiewski MM, Taub R, Lambris JD: A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-kappaB inhibitor, IkappaBalpha. Hepatology. 2005, 42: 1148-1157. 10.1002/hep.20879.CrossRef DeAngelis RA, Markiewski MM, Taub R, Lambris JD: A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-kappaB inhibitor, IkappaBalpha. Hepatology. 2005, 42: 1148-1157. 10.1002/hep.20879.CrossRef
21.
go back to reference Plumpe J, Malek NP, Bock CT, Rakemann T, Manns MP, Trautwein C: NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration. Am J Physiol Gastrointest Liver Physiol. 2000, 278: 173-183. Plumpe J, Malek NP, Bock CT, Rakemann T, Manns MP, Trautwein C: NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration. Am J Physiol Gastrointest Liver Physiol. 2000, 278: 173-183.
22.
go back to reference Shin S, Wakabayashi J, Yates MS, Wakabayashi N, Dolan PM, Aja S, Liby KT, Sporn MB, Yamamoto M, Kensler TW: Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. Eur J Pharmacol. 2009, 620: 138-144. 10.1016/j.ejphar.2009.08.022.CrossRef Shin S, Wakabayashi J, Yates MS, Wakabayashi N, Dolan PM, Aja S, Liby KT, Sporn MB, Yamamoto M, Kensler TW: Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. Eur J Pharmacol. 2009, 620: 138-144. 10.1016/j.ejphar.2009.08.022.CrossRef
23.
go back to reference Tanaka Y, Aleksunes LM, Yeager RL, Gyamfi MA, Esterly N, Guo GL, Klaassen CD: NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. J Pharmacol Exp Ther. 2008, 325: 655-664. 10.1124/jpet.107.135822.CrossRef Tanaka Y, Aleksunes LM, Yeager RL, Gyamfi MA, Esterly N, Guo GL, Klaassen CD: NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. J Pharmacol Exp Ther. 2008, 325: 655-664. 10.1124/jpet.107.135822.CrossRef
24.
go back to reference Dogukan A, Sahin N, Tuzcu M, Juturu V, Orhan C, Onderci M, Komorowski J, Sahin K: The effects of chromium histidinate on mineral status of serum and tissue in fat-fed and streptozotocin-treated type II diabetic rats. Biol Trace Elem Res. 2009, 131: 124-132. 10.1007/s12011-009-8351-8.CrossRef Dogukan A, Sahin N, Tuzcu M, Juturu V, Orhan C, Onderci M, Komorowski J, Sahin K: The effects of chromium histidinate on mineral status of serum and tissue in fat-fed and streptozotocin-treated type II diabetic rats. Biol Trace Elem Res. 2009, 131: 124-132. 10.1007/s12011-009-8351-8.CrossRef
25.
go back to reference Farombi EO, Shrotriya S, Na HK: Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem Toxicol. 2008, 46: 1279-1287. 10.1016/j.fct.2007.09.095.CrossRef Farombi EO, Shrotriya S, Na HK: Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem Toxicol. 2008, 46: 1279-1287. 10.1016/j.fct.2007.09.095.CrossRef
26.
go back to reference Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem. 1951, 193: 165-175. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem. 1951, 193: 165-175.
27.
go back to reference SAS: SAS® User's Guide: Statistics (Version 9th.). 2002, Statistical Analysis System Institute Inc., Cary, NC, USA SAS: SAS® User's Guide: Statistics (Version 9th.). 2002, Statistical Analysis System Institute Inc., Cary, NC, USA
28.
go back to reference Kim JY, Nolte LA, Hansen PA, Han DH, Ferguson K, Thompson PA, Holloszy JO: High-fat diet-induced muscle insulin resistance: relationship to visceral fat mass. Am J Physiol Regul Integr Comp Physiol. 2000, 279: 2057-2065. Kim JY, Nolte LA, Hansen PA, Han DH, Ferguson K, Thompson PA, Holloszy JO: High-fat diet-induced muscle insulin resistance: relationship to visceral fat mass. Am J Physiol Regul Integr Comp Physiol. 2000, 279: 2057-2065.
29.
go back to reference Bray GA, Paeratakul S, Popkin BM: Dietary fat and obetisy: a review of animal, clinical and epidemiological studies. Physiol Behav. 2004, 83: 549-555. 10.1016/j.physbeh.2004.08.039.CrossRef Bray GA, Paeratakul S, Popkin BM: Dietary fat and obetisy: a review of animal, clinical and epidemiological studies. Physiol Behav. 2004, 83: 549-555. 10.1016/j.physbeh.2004.08.039.CrossRef
30.
go back to reference Caballero AE: Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation. Arch Med Res. 2005, 36: 241-249. 10.1016/j.arcmed.2005.03.013.CrossRef Caballero AE: Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation. Arch Med Res. 2005, 36: 241-249. 10.1016/j.arcmed.2005.03.013.CrossRef
31.
go back to reference Decorde K, Teissedre PL, Sutra T, Ventura E, Cristol JP, Rouanet JM: Chardonnay grape seed procyanidin extract supplementation prevents high-fat diet-induced obesity in hamsters by improving adipokine imbalance and oxidative stress markers. Mol Nutr Food Res. 2009, 53: 659-666. 10.1002/mnfr.200800165.CrossRef Decorde K, Teissedre PL, Sutra T, Ventura E, Cristol JP, Rouanet JM: Chardonnay grape seed procyanidin extract supplementation prevents high-fat diet-induced obesity in hamsters by improving adipokine imbalance and oxidative stress markers. Mol Nutr Food Res. 2009, 53: 659-666. 10.1002/mnfr.200800165.CrossRef
32.
go back to reference Anderson RA: Chromium and insulin resistance. Nutr Res Rev. 2003, 16: 267-275. 10.1079/NRR200366.CrossRef Anderson RA: Chromium and insulin resistance. Nutr Res Rev. 2003, 16: 267-275. 10.1079/NRR200366.CrossRef
33.
go back to reference Vincent JB: The biochemistry of chromium. J Nutr. 2000, 130: 715-718. Vincent JB: The biochemistry of chromium. J Nutr. 2000, 130: 715-718.
34.
go back to reference SK Jain, Croad JL, Velusamy T, Rains JL, Bull R: Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 in livers of zucker diabetic fatty rats. Mol Nutr Food Res. 2010, 54: 1371-1380. 10.1002/mnfr.200900177.CrossRef SK Jain, Croad JL, Velusamy T, Rains JL, Bull R: Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 in livers of zucker diabetic fatty rats. Mol Nutr Food Res. 2010, 54: 1371-1380. 10.1002/mnfr.200900177.CrossRef
35.
go back to reference Jain SK, Lim G: Chromium chloride inhibits TNFalpha and IL-6 secretion in isolated human blood mononuclear cells exposed to high glucose. Horm Metab Res. 2006, 38: 60-62. 10.1055/s-2006-924981.CrossRef Jain SK, Lim G: Chromium chloride inhibits TNFalpha and IL-6 secretion in isolated human blood mononuclear cells exposed to high glucose. Horm Metab Res. 2006, 38: 60-62. 10.1055/s-2006-924981.CrossRef
36.
go back to reference Jain SK, Rains JL, Croad JL: Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Rad Biol Med. 2007, 43: 1124-1131. 10.1016/j.freeradbiomed.2007.05.019.CrossRef Jain SK, Rains JL, Croad JL: Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Rad Biol Med. 2007, 43: 1124-1131. 10.1016/j.freeradbiomed.2007.05.019.CrossRef
37.
go back to reference Zhang M, Lv XY, Li J, Xu ZG, Chen L: The characterization of high-fat diet multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res. 2008, 704045- Zhang M, Lv XY, Li J, Xu ZG, Chen L: The characterization of high-fat diet multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res. 2008, 704045-
38.
go back to reference Amin KA, Nagy MA: Effect of Carnitine and herbal mixture extract on obesity induced by high fat diet in rats. Diabetol Metab Syndr. 2009, 1: 1-17. 10.1186/1758-5996-1-1.CrossRef Amin KA, Nagy MA: Effect of Carnitine and herbal mixture extract on obesity induced by high fat diet in rats. Diabetol Metab Syndr. 2009, 1: 1-17. 10.1186/1758-5996-1-1.CrossRef
39.
go back to reference Vincent JB, Bennett R: Potential and purported roles for chromium in insulin signaling: The search for the holy grail. The Nutritional Biochemistry of Chromium (III). Edited by: Vincent JB. 2007, Elsevier BV, 139-160.CrossRef Vincent JB, Bennett R: Potential and purported roles for chromium in insulin signaling: The search for the holy grail. The Nutritional Biochemistry of Chromium (III). Edited by: Vincent JB. 2007, Elsevier BV, 139-160.CrossRef
40.
go back to reference Bhattacharya A, Rahman MM, McCarter R: Conjugated linoleic acid and chromium lower body weight and visceral fat mass in high-fat-diet-fed mice. Lipids. 2006, 41: 437-444. 10.1007/s11745-006-5117-3.CrossRef Bhattacharya A, Rahman MM, McCarter R: Conjugated linoleic acid and chromium lower body weight and visceral fat mass in high-fat-diet-fed mice. Lipids. 2006, 41: 437-444. 10.1007/s11745-006-5117-3.CrossRef
41.
go back to reference Niu N, Yu YH, Wang Y: Combined effects of niacin and chromium treatment on vascular endothelial dysfunction in hyperlipidemic rats. Mol Biol Rep. 2009, 36: 1275-1281. 10.1007/s11033-008-9309-1.CrossRef Niu N, Yu YH, Wang Y: Combined effects of niacin and chromium treatment on vascular endothelial dysfunction in hyperlipidemic rats. Mol Biol Rep. 2009, 36: 1275-1281. 10.1007/s11033-008-9309-1.CrossRef
42.
go back to reference Anderson RA, Polansky MM, Bryden NA, Canary JJ: Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia. Metabolism. 1987, 36: 351-355. 10.1016/0026-0495(87)90206-X.CrossRef Anderson RA, Polansky MM, Bryden NA, Canary JJ: Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia. Metabolism. 1987, 36: 351-355. 10.1016/0026-0495(87)90206-X.CrossRef
43.
go back to reference Chen WY, Chen CJ, Liu CH, Mao FC: Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice. Diabetes Obes Metab. 2009, 11: 293-303. 10.1111/j.1463-1326.2008.00936.x.CrossRef Chen WY, Chen CJ, Liu CH, Mao FC: Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice. Diabetes Obes Metab. 2009, 11: 293-303. 10.1111/j.1463-1326.2008.00936.x.CrossRef
44.
go back to reference Cefalu WT, Wang ZQ, Zhang XH, Baldor LC, Russell JC: Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr. 2002, 132: 1107-1114. Cefalu WT, Wang ZQ, Zhang XH, Baldor LC, Russell JC: Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr. 2002, 132: 1107-1114.
45.
go back to reference Chen GL, Liu P, Pattar G, Tackett L, Bhonagiri P, Strawbridge AB, Elmendorf JS: Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol Endocrinol. 2006, 20: 857-870.CrossRef Chen GL, Liu P, Pattar G, Tackett L, Bhonagiri P, Strawbridge AB, Elmendorf JS: Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol Endocrinol. 2006, 20: 857-870.CrossRef
46.
go back to reference Zhang X, Dong F, Ren J, Driscoll MJ, Culver B: High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex. Exp Neurol. 2005, 191: 318-325. 10.1016/j.expneurol.2004.10.011.CrossRef Zhang X, Dong F, Ren J, Driscoll MJ, Culver B: High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex. Exp Neurol. 2005, 191: 318-325. 10.1016/j.expneurol.2004.10.011.CrossRef
47.
go back to reference Fan JG, Qian Y, Zheng XY, Cai XB, Lu YS: Effects of pentoxifylline on hepatic nuclear factor-kappa B signaling pathway and insulin resistance in nonalcoholic steatohepatitis rats induced by fat-rich diet. Zhonghua Gan Zang Bing Za Zhi. 2006, 14: 762-766. Fan JG, Qian Y, Zheng XY, Cai XB, Lu YS: Effects of pentoxifylline on hepatic nuclear factor-kappa B signaling pathway and insulin resistance in nonalcoholic steatohepatitis rats induced by fat-rich diet. Zhonghua Gan Zang Bing Za Zhi. 2006, 14: 762-766.
48.
go back to reference Kobayashi A, Kang MI, Watai Y, Tong KI, Shibata T, Uchida K, Yamamoto M: Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol. 2006, 26: 221-229. 10.1128/MCB.26.1.221-229.2006.CrossRef Kobayashi A, Kang MI, Watai Y, Tong KI, Shibata T, Uchida K, Yamamoto M: Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol. 2006, 26: 221-229. 10.1128/MCB.26.1.221-229.2006.CrossRef
49.
go back to reference He XY, Zhao GJ, Lu ZQ, Hong GL, He F, Liang H, Qiu QM, Li JR: Oxidative stress of acute paraquat poisoned rats and sodium dimercaptopropane sulfonate intervention. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2009, 27: 476-479. He XY, Zhao GJ, Lu ZQ, Hong GL, He F, Liang H, Qiu QM, Li JR: Oxidative stress of acute paraquat poisoned rats and sodium dimercaptopropane sulfonate intervention. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2009, 27: 476-479.
50.
go back to reference Okawa H, Motohashi H, Kobayashi A, Aburatani H, Kensler TW, Yamamoto M: Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem Biophys Res Commun. 2006, 339: 79-88. 10.1016/j.bbrc.2005.10.185.CrossRef Okawa H, Motohashi H, Kobayashi A, Aburatani H, Kensler TW, Yamamoto M: Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem Biophys Res Commun. 2006, 339: 79-88. 10.1016/j.bbrc.2005.10.185.CrossRef
51.
go back to reference Beltowski J, Wojcicka G, Gorny D, Marciniak A: The effect of dietary-induced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity. J Physiol Pharmacol. 2000, 51: 883-896. Beltowski J, Wojcicka G, Gorny D, Marciniak A: The effect of dietary-induced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity. J Physiol Pharmacol. 2000, 51: 883-896.
52.
go back to reference Amirkhizi F, Siassi F, Minaie S, Djalali M, Rahimi A, Chamari M: Is obesity associated with increased plasma lipid peroxidation and oxidative stress in women?. ARYA Atheroscler J. 2007, 2: 189-192. Amirkhizi F, Siassi F, Minaie S, Djalali M, Rahimi A, Chamari M: Is obesity associated with increased plasma lipid peroxidation and oxidative stress in women?. ARYA Atheroscler J. 2007, 2: 189-192.
53.
go back to reference Feillet-Coudraya C, Sutrab T, Foureta G, Ramos J, Wrutniak-Cabello C, Cabello G, Cristol JP, Coudray C: Oxidative stress in rats fed a high-fat high-sucrose diet and preventive effect of polyphenols: Involvement of mitochondrial and NAD(P)H oxidase systems. Free Radic Biol Med. 2009, 46: 624-632. 10.1016/j.freeradbiomed.2008.11.020.CrossRef Feillet-Coudraya C, Sutrab T, Foureta G, Ramos J, Wrutniak-Cabello C, Cabello G, Cristol JP, Coudray C: Oxidative stress in rats fed a high-fat high-sucrose diet and preventive effect of polyphenols: Involvement of mitochondrial and NAD(P)H oxidase systems. Free Radic Biol Med. 2009, 46: 624-632. 10.1016/j.freeradbiomed.2008.11.020.CrossRef
54.
go back to reference Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004, 114: 1752-1761.CrossRef Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004, 114: 1752-1761.CrossRef
Metadata
Title
Impact of chromium histidinate on high fat diet induced obesity in rats
Authors
Mehmet Tuzcu
Nurhan Sahin
Cemal Orhan
Can Ali Agca
Fatih Akdemir
Zeynep Tuzcu
James Komorowski
Kazim Sahin
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Nutrition & Metabolism / Issue 1/2011
Electronic ISSN: 1743-7075
DOI
https://doi.org/10.1186/1743-7075-8-28

Other articles of this Issue 1/2011

Nutrition & Metabolism 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.